stocksKPL
KPL

Kwality Pharmaceuticals Ltd.

3,361.10-273.7 (-7.53%)
21 Aug, 12:00 AM

Annual Reports and Financial Documents

Kwality Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20162017201820192020202120222023202420252026
Annual ReportsFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Kwality Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Newspaper Publication13 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Unaudited Financial Results for the quarter ended June 30, 2026.
  2. Newspaper Publication12 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Notice of 43rd Annual General Meeting.
  3. Analyst / Investor Meet12 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Outcome of Investors/Analysts Meeting held on August 10, 2026
  4. Outcome of Board Meeting10 Aug 2026
    Board Meeting Outcome for Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015
    Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations, 2015
  5. AGM9 Aug 2026
    Notice Convening The 43Rd Annual General Meeting ("AGM") Of The Company On Monday, 31St August, 2026 At 12 :00 Noon. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OA VM).
    NOTICE OF 43RD AGM IS ENCLOSED
  6. Reg. 34 (1) Annual Report9 Aug 2026
    Reg. 34 (1) Annual Report.
    Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations, 2015, as amended ('' Listing Regulations''), please find attached herewith the Annual Report of the Company for the FY ....
  7. General8 Aug 2026
    Intimation Of Book Closure
    Intimation of Book Closure.
  8. General8 Aug 2026
    Intimation Of 43Rd Annual General Meeting
    Intimation of 43rd AGM
  9. Outcome without intimation8 Aug 2026
    Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM
    This is to inform you, pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Board of Directors ....
  10. Analyst / Investor Meet4 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Earnings Conference Call for Q1 FY 2026-27
  11. Analyst / Investor Meet4 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Earnings Conference Call for Q1 FY 2026-27
  12. Analyst / Investor Meet4 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Earnings Conference Call for Q1 FY 2026-27
  13. Board Meeting3 Aug 2026
    Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30-06-2026.
    Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Standalone and ....
  14. General24 Jul 2026
    Disclosure Under Regulation 30 Of SEBI LODR
    Kwality Pharmaceuticals receives CDSCO Nod to Initiate Preclinical Pilot Batches of Pembroluzimab
  15. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30-06-2026.
  16. Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  17. Resignation of Director2 Jun 2026
    Announcement under Regulation 30 (LODR)-Resignation of Director
    Resignation of Mr. Kartik Kapur, Independent Director of the Company.
  18. Change in Management2 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Mr. Swanith Kapoor as Additional (Non-Executive, Independent) Director and Resignation of Mr. Kartik Kapur, Independent Director of the Company.
  19. Reg.24(A)-Annual Secretarial Compliance30 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for the year ended 31-03-2026 is enclosed herewith
  20. Analyst / Investor Meet28 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio recording of quarterly earning conference call

Frequently Asked Questions

Where can I download the annual report of Kwality Pharmaceuticals Ltd.?
Annual reports of Kwality Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Kwality Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Kwality Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Kwality Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Kwality Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Kwality Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Kwality Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Kwality Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Kwality Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Kwality Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Kwality Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Kwality Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Kwality Pharmaceuticals Ltd. is INE552U01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Kwality Pharmaceuticals Ltd. listed?
Kwality Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is KPL and the BSE code is -.
Where can I find the shareholding pattern of Kwality Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Kwality Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Kwality Pharmaceuticals Ltd. on Sharpely?
Share price data for Kwality Pharmaceuticals Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.